Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial
Xiaofeng Tang,Biaolong Deng,Aiping Zang,Xiaowen He,Ye Zhou,Daimeng Wang,Dan Li,Xueyu Dai,Jieqiong Chen,Xuhua Zhang,Ye Liu,Yonghua Xu,Jingjing Chen,Weijie Zheng,Luding Zhang,Constance Gao,Huanfeng Yang,Bin Li,Xueqi Wang
DOI: https://doi.org/10.3389/fimmu.2022.940577
IF: 7.3
2022-09-29
Frontiers in Immunology
Abstract:Background Aging is usually accompanied by functional declines of the immune system, especially in T-cell responses. However, little is known about ways to alleviate this. Methods Here, 37 middle-aged healthy participants were recruited, among which 32 were intravenously administrated with expanded NK cells and 5 with normal saline. Then, we monitored changes of peripheral senescent and exhausted T cells within 4 weeks after infusion by flow cytometry, as well as serum levels of senescence-associated secretory phenotype (SASP)-related factors. In vitro co-culture assays were performed to study NK-mediated cytotoxic activity against senescent or exhausted T cells. Functional and phenotypic alteration of NK cells before and after expansion was finally characterized. Results After NK cell infusion, s enescent CD28 - , CD57 + , CD28 - CD57 + , and CD28 - KLRG1 + CD4 + and CD8 + T-cell populations decreased significantly, so did PD-1 + and TIM-3 + T cells. These changes were continuously observed for 4 weeks. Nevertheless, no significant changes were observed in the normal saline group. Moreover, SASP-related factors including IL-6, IL-8, IL-1α, IL-17, MIP-1α, MIP-1β, and MMP1 were significantly decreased after NK cell infusion. Further co-culture assays showed that expanded NK cells specifically and dramatically eliminated senescent CD4 + T cells other than CD28 + CD4 + T cells. They also showed improved cytotoxic activity, with different expression patterns of activating and inhibitory receptors including NKG2C, NKG2A, KLRG1, LAG3, CD57, and TIM3. Conclusion Our findings imply that T-cell senescence and exhaustion is a reversible process in healthy individuals, and autologous NK cell administration can be introduced to alleviate the aging. Clinical Trial Registration ClinicalTrials.gov , ChiCTR-OOh-17011878.
immunology